Genomics' drug development commercial biomarker lifecycle value — the application of genomic biomarkers across the complete pharmaceutical drug development cycle — from target identification using human genetic association studies through patient enrichment biomarkers in clinical trial design through companion diagnostic development through post-approval pharmacogenomic...